Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
Viral Immunol ; 30(7): 500-507, 2017 09.
Article in English | MEDLINE | ID: mdl-28598267

ABSTRACT

Intravenous immunoglobulin (IVIG) is used to treat or prevent severe viral infection, especially cytomegalovirus (CMV) infections. IVIG was characterized to understand its interaction with CMV-infected cells. IVIG retarded CMV spread and reduced virus yields depending on the neutralizing (NT) antibody titer. Immediate early protein synthesis was reduced by IVIG in 3 to 15 h, and IVIG specifically reduced the ratio of 66/68k protein synthesis among immediate early proteins in an NT antibody-dependent manner between 4 and 8 h after infection, indicating that antigenic modulation of CMV-infected cells by IVIG reduced viral protein synthesis and virus production. The half-life of antibody bound to CMV-infected cells was 3.8 h. NT antibody titers to varicella-zoster virus (VZV) and CMV in IVIG were dose dependently absorbed by cells infected with VZV and CMV, respectively, but the antibody titers to CMV and VZV, respectively, were not affected. NT antibody in 0.3 mL of IVIG (15 mg) was specifically absorbed by 108 CMV-infected cells and 107 VZV-infected cells, suggesting that the NT antibody in IVIG might be inactivated by one-tenth of a similar volume of CMV-infected or VZV-infected cells. Various antiviral activities of IVIG may contribute to control and alleviation of CMV infection.


Subject(s)
Antibodies, Neutralizing/immunology , Cytomegalovirus Infections/immunology , Cytomegalovirus/immunology , Immunoglobulin G/immunology , Antibodies, Viral/immunology , Antigenic Modulation , Antiviral Agents/immunology , Cells, Cultured , Humans , Immediate-Early Proteins/metabolism , Immunoglobulin G/metabolism , Immunoglobulins, Intravenous/immunology , Neutralization Tests , Virus Release/immunology
2.
J Med Virol ; 79(4): 413-25, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17311334

ABSTRACT

Hepatitis is caused by hepatitis viruses, but hepatitis or hepatocellular enzyme abnormalities is sometimes associated with infection by the hepatiticomimetic viruses. The direct and indirect effects of infection with hepatiticomimetic viruses were examined in two human hepatocyte systems. Poliovirus, adenovirus, and herpes simplex virus (HSV) induced cytopathology in Hep G2 cells. Measles virus caused no change in hepatocytes. Poliovirus infection did not affect cellular protein synthesis, and the peak of hepatocellular enzyme release coincided with the peak of virus release. The increase in adenovirus protein synthesis correlated with the decrease of transferrin synthesis, and enzyme release was not prominent. HSV induced viral protein synthesis with enhanced processing and inhibition of synthesis of alpha1-antitrypsin. The peak of enzyme release was later than the peak of virus release. In primary hepatocytes, poliovirus, adenovirus, and induced extensive cytopathology and enzyme release, and VZV caused cytopathology and significant but minute enzyme release. The ratio of lactate dehydrogenase to aspartate aminotransferase release was larger in poliovirus infection in both hepatocytes than in HSV or VZV infection. Although poliovirus and adenovirus are released by cytolysis and HSV and VZV are secreted by exocytosis of cytoplasmic vacuoles, enzyme release was independent of the type of virus release. Adenovirus showed strong cytotoxicity but did not modify the membrane nor cause enzyme release. Enzyme release was associated with modification of the surface membrane due to apoptosis with poliovirus and necrosis with HSV. Consequently hepatocellular injury by viral infection did not reflect the amount or pattern of hepatocellular enzyme release.


Subject(s)
Adenoviridae Infections/virology , Adenoviridae/physiology , Herpes Simplex/virology , Herpes Zoster/virology , Herpesvirus 3, Human/physiology , Measles/virology , Morbillivirus/physiology , Poliomyelitis/virology , Poliovirus/physiology , Simplexvirus/physiology , Apoptosis , Aspartate Aminotransferases/metabolism , Cell Line, Tumor , Cell Membrane/pathology , Cells, Cultured , Cytopathogenic Effect, Viral , Hepatocytes/metabolism , Hepatocytes/pathology , Hepatocytes/virology , Humans , L-Lactate Dehydrogenase/metabolism , Necrosis/pathology , Species Specificity , Viral Proteins/biosynthesis
SELECTION OF CITATIONS
SEARCH DETAIL
...